EN

Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Campus life

Discover the campuses

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Join our programs

Shaker Gene.iO ATIGE

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Directories Our network

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Come to our events

Innovate with us

Discover >

Quick access

Company

StemSelect

4, rue Pierre Fontaine – Campus 3
F-91058 Evry Cedex

Phone: +33(0)6 80 76 26 51
E-mail: amarti@stemselect.com

Aurélien MARTI : CEO
Site Web >
StemSelect - Entreprise génopolitaine StemSelect - Entreprise génopolitaine

Booster#Medical device #Health&well-being

  • Stem cells
  • Cell therapy
  • Regenerative therapy

Field of activity

Our aim is to pave the way for a general access to cell therapy. We are developing a rapid isolation method of stem cells derived from one’s own fat tissue.

BACKGROUND

We came up with our technology among colleagues at Johns Hopkins University in the United States. We are now developing and optimizing our patent protected innovations in the Paris region.

DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY

Our device isolates stem cells from a patient’s liposuction sample. Our special feature is that we do not use enzymes or other products that could alter cells and we do so without sacrificing purity. Our process is completely mechanical and allows us to create a product ready to be injected into the same patient for therapeutic purposes.

  • FURTHER INFORMATION

    Patents: 2
    2 staff members
    Fund raising: €500,000
    Strengths
    Innovative technique that can quickly deliver cell therapy safely and at affordable prices.

    Innovation assets
    Innovative and safe technology with a processing time lasting less than an hour to isolate stem cells from fat.

Share
Genopole’s Companies

#Medical device

In the same field

Felome-entreprise Genopole

Felome

Felome has developed a customized genetic analysis approach using next-generation DNA sequencing technology.

Discover
Vitropep -entreprise genopole

Vitropep

Vitropep developed a unique technology allowing to inject certain peptides without cold chain and with self-administration.

Discover
CGenetix - Entreprise génopolitaine

CGenetix

CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.

Discover
Floating Genes - entreprises génopolitaines

Floating Genes

Floating Genes develops diagnostic tools for use in liquid biopsies via the highly sensitive NGS detection of circulating tumor DNA.

Discover
View all >
With the support from
Région île de France
Ministère de l'Enseignement supérieur et de la recherche AFM-Téléthon
Communauté d'agglomération Grand Paris Sud
Département de l'Essonne - Terre D'avenirs Ville d'Evry-Courcouronnes 2023 CEA Inserm Centre hospitalier Sud Francilien Université d'Evry - Paris Saclay Université PAris-Saclay SEM Genopole

Keep up to date with Genopole’s latest events and news